Treatment of midgestational placental haemorrhage with recombinant factor VIIa.
Krafft
Alexander
A
Clinic of Obstetrics, Department of Obstetrics and Gynaecology, University Hospital Zurich, Frauenklinikstrasse 10, CH 8091 Zurich, Switzerland. alexander.krafft@usz.ch
Asmis
Lars M
LM
Zimmermann
Roland
R
D000328:Adult; D002585:Cesarean Section; D003029:Coagulants / Q000627:therapeutic use*; D015942:Factor VIIa / Q000627:therapeutic use*; D005260:Female; D005322:Premature Rupture of Fetal Membranes; D005865:Gestational Age; D006406:Hematoma / Q000188:drug therapy; D006470:Hemorrhage / Q000000981:diagnostic imaging / Q000188:drug therapy*; D006801:Humans; D050498:Live Birth; D010922:Placenta Diseases / Q000000981:diagnostic imaging / Q000188:drug therapy*; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000000981:diagnostic imaging / Q000188:drug therapy*; D011994:Recombinant Proteins / Q000627:therapeutic use; D016896:Treatment Outcome; D016216:Ultrasonography, Prenatal
D003029:Coagulants; D011994:Recombinant Proteins; C103587:recombinant FVIIa; D015942:Factor VIIa